Nanobiotix S.A.
NANO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €143 | €244 | €126 | €254 |
| - Cash | €50 | €75 | €39 | €84 |
| + Debt | €51 | €51 | €53 | €46 |
| Enterprise Value | €144 | €219 | €141 | €216 |
| Revenue | -€12 | €30 | €5 | €0 |
| % Growth | -138.6% | 529.4% | 47,660% | – |
| Gross Profit | -€12 | €30 | €3 | €3 |
| % Margin | 100% | 100% | 68.6% | 26,470% |
| EBITDA | -€62 | -€30 | -€54 | -€46 |
| % Margin | 530.8% | -100.1% | -1,126.2% | -456,050% |
| Net Income | -€68 | -€40 | -€57 | -€47 |
| % Margin | 586.9% | -132.1% | -1,194.3% | -470,030% |
| EPS Diluted | -1.44 | -1.08 | -1.64 | -1.35 |
| % Growth | -33.3% | 34.1% | -21.5% | – |
| Operating Cash Flow | -€20 | -€12 | -€38 | -€31 |
| Capital Expenditures | -€1 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€20 | -€13 | -€38 | -€31 |